awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26863585-6F7FD061-8CAE-4D2F-937F-3CB793C13B7C
Q26863585-6F7FD061-8CAE-4D2F-937F-3CB793C13B7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26863585-6F7FD061-8CAE-4D2F-937F-3CB793C13B7C
Systems biology of cisplatin resistance: past, present and future
P2860
Q26863585-6F7FD061-8CAE-4D2F-937F-3CB793C13B7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26863585-6F7FD061-8CAE-4D2F-937F-3CB793C13B7C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d19dc202764764d8206760f96dc053721a23559
P2860
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.